Mark Jezyk

Mark Jezyk is currently an Asset Strategy Lead in Oncology at AbbVie, focusing on pipeline commercial strategies and brand planning. With a background that includes roles as a Postdoctoral Research Fellow at Harvard Medical School and the National Institute of Environmental Health Sciences, they transitioned into consulting with Defined Health and inVentiv Health Consulting, specializing in early commercial strategy and market research. Previously, Mark held various leadership positions at AbbVie, including Director roles in Oncology, where they significantly contributed to the brand strategy for key therapeutic areas, demonstrating expertise in opportunity assessment and commercial operations. Mark earned their medical degree from the University of North Carolina at Chapel Hill School of Medicine.